ARCHIVES

Andrew von Eschenbach Sworn In As NCI Director.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Group Opposes Bill To Allow Drug Sales After Phase I.

May 26, 2006

Hatch Hearing Turns Up Few New Deficiencies In NCI Contract Management; DeVita Blasted On Strauss

June 5, 1981

ASCO Highlights Seven of 4,000 Abstracts Submitted for Annual Meeting, June 3-7

May 27, 2011

Impath Buys Clinical Studies Support Services Network.

September 28, 2001

Blacks, Whites Have Same Contralateral Breast Cancer Risk While On Tamoxifen

December 31, 2004

NCAB Committee To Propose Event Marking Cancer Act

August 2, 1991